Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Sr.V. P. & C.C.O. | June 28, 2019 | July 02, 2019 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 12, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date June 28, 2019 · Filed July 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 24,428 |
Reported balance
After 2019-06-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-06-28 · Exercise / conversion · Acquired 7,000 · Balance 24,428 F1: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 17,428 |
Reported balance
After 2019-06-28 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2019-06-28 · Sale · Disposed 7,000 · Balance 17,428 F1: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F3: Price reflects a weighted average sale price for multiple transactions ranging from $147.00 to $147.24 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-06-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-06-28 · Exercise / conversion · Disposed 7,000 · Balance 0 F2: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. |
Filing footnotes · ownership attribution and instrument terms
F1: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019.
F2: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
F3: Price reflects a weighted average sale price for multiple transactions ranging from $147.00 to $147.24 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023.
Varex Imaging Corp
Report date February 12, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,331 |
Reported balance
After 2026-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 12,331 · Balance 12,331 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FIRST FINANCIAL BANCORP /OH/
Report date May 26, 2020 · Filed May 27, 2020
Section 16 reporting ended · disclosed 2020-05-27. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
MAINSOURCE FINANCIAL GROUP
Report date April 01, 2018 · Filed April 03, 2018
Section 16 reporting ended · disclosed 2018-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-04-01 transaction · row 1
1 source rowRow 1 · 2018-04-01 · Disposition to issuer · Disposed 16,712 · Balance 0 F1: On April 1, 2018, MainSource completed its previously announced merger (the "Merger") with First Financial Bancorp, pursuant to an Agreement and Plan of Merger, dated as of July 25, 2017, between MainSource and First Financial. In accordance with the terms of the Merger Agreement, at the effective time of the Merger each share of MainSource common stock issued an outstanding immediately prior to the Merger was converted into the right to receive 1.3875 shares of common stock of First Financial Bancorp. A cash payment of equal value was made in lieu of the issuance of fractional share |
Filing footnotes · ownership attribution and instrument terms
F1: On April 1, 2018, MainSource completed its previously announced merger (the "Merger") with First Financial Bancorp, pursuant to an Agreement and Plan of Merger, dated as of July 25, 2017, between MainSource and First Financial. In accordance with the terms of the Merger Agreement, at the effective time of the Merger each share of MainSource common stock issued an outstanding immediately prior to the Merger was converted into the right to receive 1.3875 shares of common stock of First Financial Bancorp. A cash payment of equal value was made in lieu of the issuance of fractional share
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 17,441 · Balance 0 F1: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 5,360 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 7,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 10,000 · Balance 0 F5: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 7,000 · Balance 0 F6: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 10,000 · Balance 0 F7: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 9,332 · Balance 0 F8: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option
F8: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2017 Filed Jun 19, 2017 16:46 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 3,795 | $82.00 | $311,190.00 |
DisclosureSEC source: 0001209191-17-040862 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,810 F1 · kind: This exercise and sale of a total of 3,795 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. F2 · balance_after: 6,625 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 2, 2017; 625 on May 28, 2018; 500 on May 30, 2018; 750 on May 30, 2018; 500 on June 1, 2018; 375 on October 1, 2018; 625 on May 28, 2019; 500 on May 30, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020 and 500 on June 1, 2021. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 16:46 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 3,795 | $29.94 | $113,622.30 |
DisclosureSEC source: 0001209191-17-040862 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of a total of 3,795 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:36 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0001209191-17-037275 · doc4.xml · derivative · entry 4 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,000 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 4,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 4,000 STERIS common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:36 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 165 | $79.26 | $13,077.90 |
DisclosureSEC source: 0001209191-17-037275 · doc4.xml · nonDerivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,810 F2 · shares: 165 shares were withheld from the 500 restricted shares that vested on June 1, 2017. These 165 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2017. The remaining restrictions on these ordinary shares lapse as follows: 500 on June 1, 2018; 500 on June 3, 2019 and 500 on June 1, 2020. F3 · balance_after: 6,625 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 2, 2017; 625 on May 28, 2018; 500 on May 30, 2018; 750 on May 30, 2018; 500 on June 1, 2018; 375 on October 1, 2018; 625 on May 28, 2019; 500 on May 30, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020 and 500 on June 1, 2021. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:36 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 4,000 | $79.00 | $316,000.00 |
DisclosureSEC source: 0001209191-17-037275 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,975 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:36 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 4,000 | $36.09 | $144,360.00 |
DisclosureSEC source: 0001209191-17-037275 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 4,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:32 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 148 | $77.56 | $11,478.88 |
DisclosureSEC source: 0001209191-17-036793 · doc4.xml · nonDerivative · entry 4 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,975 F4 · shares: 148 shares were withheld from the 450 restricted shares that vested on May 31, 2017. These 148 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 450 ordinary shares were awarded to Ms. Bardwell on May 31, 2013 as part of an award of 1,800 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2017. F5 · balance_after: 7,125 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 1, 2017; 375 on October 2, 2017; 625 on May 28, 2018; 500 on May 30, 2018; 750 on May 30, 2018; 500 on June 1, 2018; 375 on October 1, 2018; 625 on May 28, 2019; 500 on May 30, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020 and 500 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:32 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-17-036793 · doc4.xml · derivative · entry 5 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2027-05-30 F6 · derivative.exercise_date: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:32 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 247 | $77.07 | $19,036.29 |
DisclosureSEC source: 0001209191-17-036793 · doc4.xml · nonDerivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,123 F3 · shares: 247 shares were withheld from the 750 restricted shares that vested on May 30, 2017. These 247 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 750 ordinary shares were awarded to Ms. Bardwell on May 30, 2014 as part of an award of 3,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2017. The remaining restrictions on these ordinary shares lapse as follows: 750 on May 30, 2018. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:32 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 206 | $77.07 | $15,876.42 |
DisclosureSEC source: 0001209191-17-036793 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,370 F2 · shares: 206 shares were withheld from the 625 restricted shares that vested on May 30, 2017. These 206 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 625 ordinary shares were awarded to Ms. Bardwell on August 10, 2015 as part of an award of 2,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2017. The remaining restrictions on these ordinary shares lapse as follows: 625 on May 28, 2018; and 625 on May 28, 2019. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:32 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036793 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,576 F1 · shares: All 2,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on May 30, 2018; 500 on May 30, 2019; 500 on June 1, 2020 and 500 on June 1, 2021. Read SEC document |
| May 08, 2017 Filed May 8, 2017 15:38 UTC | MAINSOURCE FINANCIAL GROUP MSFG · Entity 167861 | GrantCommon Stock | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006813 · edgar.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,712 Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:45 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,275 | $0.00 Strike: $31.87 | $0.00 |
DisclosureSEC source: 0001209191-17-030362 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,275 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,275 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 4,275 STERIS Corporation common shares for $31.87 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:45 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 4,275 | $75.00 | $320,625.00 |
DisclosureSEC source: 0001209191-17-030362 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,576 F2 · balance_after: 6,950 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 1, 2017; 500 on June 1, 2018; 500 on June 3, 2019; 500 on June 1, 2020; 625 on May 30, 2017; 625 on May 28, 2018; 625 on May 28, 2019; 750 on May 30, 2017; 750 on May 30, 2018; 450 on May 31, 2017; 375 on October 2, 2017; 375 on October 1, 2018 and 375 on October 1, 2019. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:45 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 4,275 | $31.87 | $136,244.25 |
DisclosureSEC source: 0001209191-17-030362 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 4,275 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 16:50 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | Not disclosed Strike: $34.23 | Not disclosed |
DisclosureSEC source: 0001209191-17-004187 · doc4.xml · derivative · entry 5 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,000 shares Expires 2019-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: This option to purchase 1,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 1,000 STERIS Corporation common shares for $34.23 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. F5 · derivative.exercise_date: This option to purchase 1,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 1,000 STERIS Corporation common shares for $34.23 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 16:50 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 962 | Not disclosed Strike: $22.83 | Not disclosed |
DisclosureSEC source: 0001209191-17-004187 · doc4.xml · derivative · entry 4 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 962 shares Expires 2019-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: This option to purchase 962 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 962 STERIS Corporation common shares for $22.83 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. F4 · derivative.exercise_date: This option to purchase 962 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 962 STERIS Corporation common shares for $22.83 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 16:50 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 0.10 par value | 1,962 | $68.78 | $134,946.36 |
DisclosureSEC source: 0001209191-17-004187 · doc4.xml · nonDerivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,576 F3 · balance_after: 6,950 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 1, 2017; 500 on June 1, 2018; 500 on June 3, 2019; 500 on June 1, 2020; 625 on May 30, 2017; 625 on May 28, 2018; 625 on May 28, 2019; 750 on May 30, 2017; 750 on May 30, 2018; 450 on May 31, 2017; 375 on October 2, 2017; 375 on October 1, 2018 and 375 on October 1, 2019. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 16:50 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 0.10 par value | 1,000 | $34.23 | $34,230.00 |
DisclosureSEC source: 0001209191-17-004187 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This exercise and sale of a total of 1,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 16:50 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 0.10 par value | 962 | $22.83 | $21,962.46 |
DisclosureSEC source: 0001209191-17-004187 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 962 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:36 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 0.10 par value | 178 | $72.23 | $12,856.94 |
DisclosureSEC source: 0001209191-16-144988 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,576 F1 · shares: 178 shares were withheld from the 375 restricted shares that vested on October 3, 2016. These 178 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 375 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 1,500 restricted shares. These vested shares were valued at the NYSE closing market price on October 3, 2016. The remaining restrictions on these ordinary shares lapse as follows: 375 on October 2, 2017; 375 on October 1, 2018 and 375 on October 1, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.